JNJ vs ABBV
JNJ 与 ABBV 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | JNJJohnson & Johnson | ABBVAbbVie Inc. |
|---|---|---|
| 市值 | $608.91B | $433.47B |
| 市盈率(TTM) | 29.3 | 120.9 |
| 市净率 | 7.17 | — |
| 市销率 | 6.5x | 7.1x |
| 股息率 | 2.03% | 2.69% |
| 营收 | $97.93B(TTM) | $61.16B(TTM) |
| 营收同比增长 | 6.0% | 8.6% |
| 净利润 | $21.04B(TTM) | $3.63B(TTM) |
| 净利同比增长 | 90.6% | -1.2% |
| 每股收益(稀释) | $8.62(TTM) | $2.03(TTM) |
| 息税前利润率 | 22.9% | 24.6% |
| 净资产收益率 | 31.5% | — |
| 投入资本回报率 | 16.1% | 20.0% |
| 皮氏F值 | 6/9 | — |
| 一年总回报 | +54.2% | +29.5% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:JNJ vs ABBV
| 指标 | JNJ | ABBV |
|---|---|---|
| 期末价值 | $30.9K | $66.0K |
| 总回报 | +209.3% | +560.0% |
| 年化收益 (CAGR) | +11.5% | +20.0% |
| 波动率 | 18.5% | 25.8% |
| 夏普比率 | 0.48 | 0.69 |
| 索提诺比率 | 0.68 | 0.96 |
| 最大回撤 | -27.4% | -45.1% |
基于 2600 个共同交易日,2016-03-31 → 2026-08-03 · 无风险利率 3.83%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)